Aurora Cannabis (NASDAQ:ACB - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.09) by $0.15, Zacks reports. Aurora Cannabis had a return on equity of 0.59% and a net margin of 0.42%.
Aurora Cannabis Trading Down 3.5 %
Aurora Cannabis stock traded down $0.22 during midday trading on Friday, reaching $6.03. The stock had a trading volume of 8,729,844 shares, compared to its average volume of 5,163,835. Aurora Cannabis has a 52-week low of $2.84 and a 52-week high of $9.35. The company has a fifty day moving average of $4.27 and a 200 day moving average of $5.16. The firm has a market cap of $330.81 million, a price-to-earnings ratio of 120.62 and a beta of 1.84. The company has a quick ratio of 1.88, a current ratio of 3.30 and a debt-to-equity ratio of 0.07.
Analyst Upgrades and Downgrades
ACB has been the subject of a number of recent analyst reports. Atb Cap Markets raised Aurora Cannabis from a "hold" rating to a "strong-buy" rating in a research note on Wednesday. TD Cowen began coverage on shares of Aurora Cannabis in a research report on Wednesday, December 11th. They set a "buy" rating on the stock. Finally, TD Securities upgraded shares of Aurora Cannabis to a "strong-buy" rating in a research report on Thursday, December 12th.
Get Our Latest Stock Analysis on Aurora Cannabis
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Recommended Stories
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
